Sugar and Dyslipidemia: A Double-Hit, Perfect Storm

Area of Science:

• Cardiovascular Science
• Metabolic Science
• Public Health Nutrition

Background:

• Global sugar availability has increased significantly over 50 years, linked to industrial advancements and corn subsidies.
• This surge in sugar consumption, particularly via sweetened beverages, correlates with rising cardiometabolic disorders.
• Cardiometabolic dyslipidemia, characterized by elevated triglyceride-rich lipoproteins (TRL), is a key concern.

Purpose of the Study:

• To review the role of fructose in the development of cardiometabolic dyslipidemia.
• To synthesize recent human data on the interaction between glucose and fructose in TRL metabolism.
• To highlight fructose's impact on TRL synthesis and catabolism.

Main Methods:

• Narrative review of existing scientific literature.
• Analysis of human data on fructose and glucose metabolism.
• Examination of TRL metabolism, including VLDL and chylomicrons.

Main Results:

• Fructose metabolism, particularly fructose-1-P, acts as a signaling molecule promoting fat synthesis.
• Glucose and fructose synergistically increase de novo lipogenesis, triglyceride synthesis, and VLDL production in the liver.
• Fructose elevates inhibitors (apoCIII, ANGPTL3) of lipoprotein lipase, reducing TRL catabolism and promoting atherogenic remnant accumulation.

Conclusions:

• Fructose exerts a dual, synergistic action promoting atherogenesis by increasing TRL synthesis and decreasing their catabolism.
• The interaction between glucose and fructose metabolism is critical in driving dyslipidemia.
• Findings support public health initiatives to reduce sugar intake and establish safe consumption limits.